Primary Site >> Liver Cancer

Gene >> SREBF2

  • 2011
  • 2016
  • 2017
  • 2018
Ref: Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
PMID: 21147110
Ref: The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
PMID: 27013235
Ref: SND1 overexpression deregulates cholesterol homeostasis in hepatocellular carcinoma.
PMID: 27238764
Ref: NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis.
PMID: 27862769
Ref: Pro-inflammation NF-kappaB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells.
PMID: 28100270
Ref: Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.
PMID: 29765517